Cytokinetics | CYTK - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Amgen USD 5.9B 773M 2025-12
Arca Biopharma USD 34.43M 326K 2025-12
Bayer EUR 10.33B 126M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Brainstorm Cell Therapeutics USD 2.05M 526K 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Eisai JPY 199.9B 16.22B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Geron USD 58.8M 2.31M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 10.16B 558M 2025-12
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12